These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1221 related articles for article (PubMed ID: 21727191)

  • 1. Integrating mechanisms of pulmonary fibrosis.
    Wynn TA
    J Exp Med; 2011 Jul; 208(7):1339-50. PubMed ID: 21727191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular players in lung fibrosis.
    Lekkerkerker AN; Aarbiou J; van Es T; Janssen RA
    Curr Pharm Des; 2012; 18(27):4093-102. PubMed ID: 22630084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of pulmonary fibrosis and current treatment.
    Kuwano K; Hagimoto N; Hara N
    Curr Mol Med; 2001 Nov; 1(5):551-73. PubMed ID: 11899231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of TGF-beta in pulmonary fibrosis.
    Khalil N; Greenberg AH
    Ciba Found Symp; 1991; 157():194-207; discussion 207-11. PubMed ID: 1712697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis.
    Strieter RM; Keeley EC; Burdick MD; Mehrad B
    Trans Am Clin Climatol Assoc; 2009; 120():49-59. PubMed ID: 19768162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis.
    Gharaee-Kermani M; Phan SH
    Curr Pharm Des; 2005; 11(30):3943-71. PubMed ID: 16305523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression.
    Kapoun AM; Gaspar NJ; Wang Y; Damm D; Liu YW; O'young G; Quon D; Lam A; Munson K; Tran TT; Ma JY; Murphy A; Dugar S; Chakravarty S; Protter AA; Wen FQ; Liu X; Rennard SI; Higgins LS
    Mol Pharmacol; 2006 Aug; 70(2):518-31. PubMed ID: 16707625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of pulmonary fibrosis: conference summary.
    Strieter RM
    Chest; 2001 Jul; 120(1 Suppl):77S-85S. PubMed ID: 11451940
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis.
    Grabarz F; Aguiar CF; Correa-Costa M; Braga TT; Hyane MI; Andrade-Oliveira V; Landgraf MA; Câmara NOS
    Inflammopharmacology; 2018 Apr; 26(2):491-504. PubMed ID: 28779430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of pulmonary fibrosis: is there a fibrosis gene?
    Marshall RP; McAnulty RJ; Laurent GJ
    Int J Biochem Cell Biol; 1997 Jan; 29(1):107-20. PubMed ID: 9076945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary fibrosis: a cellular overreaction or a failure of communication?
    Sheppard D
    J Clin Invest; 2001 Jun; 107(12):1501-2. PubMed ID: 11413155
    [No Abstract]   [Full Text] [Related]  

  • 13. Myofibroblast differentiation and survival in fibrotic disease.
    Kis K; Liu X; Hagood JS
    Expert Rev Mol Med; 2011 Aug; 13():e27. PubMed ID: 21861939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and mediators of pulmonary fibrosis.
    Keane MP; Strieter RM; Belperio JA
    Crit Rev Immunol; 2005; 25(6):429-63. PubMed ID: 16390322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical aspects of lung fibrosis: a spotlight on the myofibroblast.
    Hinz B
    Proc Am Thorac Soc; 2012 Jul; 9(3):137-47. PubMed ID: 22802288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets in pulmonary fibrosis: the myofibroblast in focus.
    Scotton CJ; Chambers RC
    Chest; 2007 Oct; 132(4):1311-21. PubMed ID: 17934117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Infection May Drive EC-like Myofibroblasts towards Myofibroblasts to Contribute to Pulmonary Fibrosis.
    Wu X; Zhang D; Boström KI; Yao Y
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis.
    Strieter RM; Keeley EC; Hughes MA; Burdick MD; Mehrad B
    J Leukoc Biol; 2009 Nov; 86(5):1111-8. PubMed ID: 19581373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-β production and epithelial to mesenchymal transition.
    Schneider DJ; Wu M; Le TT; Cho SH; Brenner MB; Blackburn MR; Agarwal SK
    FASEB J; 2012 Feb; 26(2):503-12. PubMed ID: 21990376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The myofibroblast in pulmonary fibrosis.
    Phan SH
    Chest; 2002 Dec; 122(6 Suppl):286S-289S. PubMed ID: 12475801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.